顯示第 17 至 32 項結果，共 42 項
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-200.0-BT)
-
Anti-Fluorescein [4-4-20 (enhanced)] (Ab00102-200.0)
-
Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8] (Ab00104-200.0-BT)
-
Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8] (Ab00104-200.0)
-
Anti-influenza [2-8C] (Ab01103-200.0-BT)
-
Anti-influenza [2-8C] (Ab01103-200.0)
-
Anti-influenza [2-12C] (Ab01105-200.0-BT)
-
Anti-influenza [2-12C] (Ab01105-200.0)
-
Anti-NS1 [ZKA25] (Ab01006-200.0-BT)
-
Anti-NS1 [ZKA25] (Ab01006-200.0)
-
Anti-Poxvirus L1 Protein [Fab 7d11] (Ab00774-200.0-BT)
-
Anti-Poxvirus L1 Protein [Fab 7d11] (Ab00774-200.0)
-
Anti-pre- and post-fusion conformation of HRSV F protein [RSB15] (Ab00252-200.0-BT)
-
Anti-pre- and post-fusion conformation of HRSV F protein [RSB15] (Ab00252-200.0)
-
Anti-RSV [RSHZ19 (Felvizumab)] (Ab00729-200.0-BT)
-
Anti-RSV [RSHZ19 (Felvizumab)] (Ab00729-200.0)